Eisai Co Ltd (OTCPK:ESAIY)
$ 8.125 -0.005 (-0.06%) Market Cap: 9.17 Bil Enterprise Value: 8.76 Bil PE Ratio: 33.71 PB Ratio: 1.74 GF Score: 70/100

Eisai Co Ltd FDA Grants Accelerated Approval for ADUHELM Presentation Transcript

Jun 09, 2021 / 02:00AM GMT
Release Date Price: $107.74 (+3.10%)
Unidentified Company Representative

Presentation
Jun 09, 2021 / 02:00AM GMT

=====================
Corporate Participants
=====================
* Haruo Naito
Eisai Co., Ltd. - CEO, Representative Corporate Officer & Director
* Ivan Cheung
Eisai Co., Ltd. - Senior VP & President of Neurology Business Group
* Shuhei Shimizu
* Teiji Kimura
Eisai Co., Ltd. - VP & Chief Discovery Officer of Neurology Business Group

=====================
Conference Call Participants
=====================
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Motoya Kohtani
Nomura Securities Co. Ltd., Research Division - Senior Analyst

=====================

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot